Mycodern Balance Sheet Health
Financial Health criteria checks 2/6
Mycodern has a total shareholder equity of PLN16.9M and total debt of PLN2.2M, which brings its debt-to-equity ratio to 12.7%. Its total assets and total liabilities are PLN26.4M and PLN9.4M respectively.
Key information
12.7%
Debt to equity ratio
zł2.15m
Debt
| Interest coverage ratio | n/a |
| Cash | zł226.08k |
| Equity | zł16.93m |
| Total liabilities | zł9.45m |
| Total assets | zł26.38m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: GY3's short term assets (PLN6.7M) do not cover its short term liabilities (PLN7.4M).
Long Term Liabilities: GY3's short term assets (PLN6.7M) exceed its long term liabilities (PLN2.1M).
Debt to Equity History and Analysis
Debt Level: GY3's net debt to equity ratio (11.4%) is considered satisfactory.
Reducing Debt: GY3's debt to equity ratio has increased from 5.8% to 12.7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: GY3 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: GY3 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 29% each year